TCL Archive Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic September 25, 1998
TCL Archive NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement March 18, 1994
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
